Crowdonomics
All companies
LoveBug Probiotics logo

LoveBug Probiotics

Operating

LOVEBUG NUTRITION INC

Retail & Consumer · New York, NY

Post-money valuation ⓘ
$16.4M
As of Dec 2017 · from Reg CF Offering (2017) · pre-money + amount raised, not a traded price
Total raised
$448,074
Across 1 round since 2017
Latest share price
$3.20
Reg CF · Common Stock · Nov 2017 offering price

Financials

FY2015–FY2018 · from SEC filings · hover any figure for its source
$68K
−$228K
2015
$470K
−$638K
2016
$2.1M
−$397K
2017
$3.1M
−$892K
2018
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2015 reviewed*
FY2016 reviewed*
FY2017
FY2018
Income statement
Revenue
$68,425
$470,257
$2,093,034
$3,099,909
Cost of goods sold
$23,120
$183,051
$769,866
$1,379,995
Gross margin
66%
61%
63%
55%
Net income
-$228,112
-$637,934
-$396,799
-$891,974
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$4,565
$178,973
$128,040
$234,344
Accounts receivable
$0
$11,097
$215,848
$349,937
Total assets
$93,992
$668,570
$596,733
$1,028,826
Short-term debt
$0
$0
$0
$42,299
Long-term debt
$0
$0
$0
$680,598
Total liabilities
$0
$0
$0
$722,896
Other
Headcount
—
6
6
5

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$16.0M
pre-money
Reg CF · Common · Nov 2017

Blue bars are the pre-money valuation the company stated for a priced round.

Cap table

Principal holders% as the filing states it, Apr 29, 2019

  • Ashley Harris87.0%of company
  • Benjamin Harris8%of company

Sold to the crowd

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Raised $448.1K / $1.1MInvestors 81Post-money $16.4M

Team

6 people
Ashley HarrisFounder
Co-Founder & CEO

Ashley is the co-founder and CEO of LoveBug Probiotics and serves on the board as Chairperson and Secretary since 2014. She is a finalist for female entrepreneur of the year in the 2017 Stevie Awards in the consumer products category for consumer products companies with less than 2,500 employees. Her life-changing experience with a severe microbiome imbalance that devastated her health and her son's led to her crusade to help others improve their gut health and overall well-being. Prior to founding the company, Ashley worked at Sotheby's. Ashley received her BA from the University of Pennsylvania and a MFA from Sotheby's Institute of Art in London.

Benjamin HarrisFounder
Co-Founder, CFO & Treasurer

Benjamin has 13 years of financial industry experience including seven years as a principal investor in private equity and credit. He is a Director of ORIX Leveraged Finance, where he is responsible for originating and executing investments in middle-market sponsor-backed companies, since 2014. Prior to joining ORIX, Benjamin worked at Prospect Capital where he focused on originating and underwriting lower middle-market principal investments. Benjamin received a BSc in Economics from University College London and a MBA from the University of Chicago Booth School of Business, where he was on the Dean’s List multiple quarters and graduated with concentrations in Entrepreneurship, Finance, and Organizational Management (Leadership). Benjamin is CFO & Treasurer of the company on a part-time basis since 2014.

Kevin Jacobson
Senior Vice President, Sales

Executive level sales professional with over 28 years of CPG sales experience in all food, drug and mass channels. Proven track record of gaining new distribution and growing year over year sales with existing accounts.

Julia Esch
Senior Brand Manager

Seasoned brand manager with over 15 years of marketing, business development and account management experience.

Martha Everhart
Director, North American Sales

Accomplished sales professional with a 20-year proven track record in the CPG industry.

Robert Banas
Director, IT

Senior IT professional with 22 years of experience managing manufacturing, finance, sales & operations platforms in multi-branded companies.

Names and titles as disclosed on SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFiled Form C-TR (terminated reporting)

Filed 1 of 9 annual reports (FY2017–FY2025)

81 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-TROct 10, 20190001721124-19-000003
    EDGAR
  • Form C-ARApr 29, 20190001721124-19-000002
    EDGAR
  • Form C-AR/AMay 1, 20180001721124-18-000001
    EDGAR
  • Form CNov 13, 20170001665160-17-000578
    EDGAR
Source: SEC EDGARCIK 0001721124NYShare price $3.20Last synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.